Quantitative Systematic Strategies LLC Avrobio, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$26.95 - $52.7 $323,912 - $633,401
-12,019 Closed
0 $0
Q2 2018

Aug 07, 2018
BUY
$28.08 - $31.2 $337,493 - $374,992
12,019 New
12,019 $343,000

Others Institutions Holding AVRO

# of Institutions
2
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email